Egyptian Biotech Reme-D Secures $1.4 Million in Latest Pre-Series A Funding Round

Egyptian Biotech Reme-D secured $1.4 million in its latest Pre-Series A, adding another data point to the Healthcare & Life Sciences funding market.

Egyptian Biotech Reme-D Raises $1.4 million in Funding

Egyptian Biotech Reme-D Raises USD 1.45 M Pre-Series A To Expand Molecular Diagnostics.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Egyptian Biotech Reme-D operates in Healthcare & Life Sciences. Egyptian Biotech Reme-D's financing adds to recent private-market activity.

Strategic Use of Funds

Expand Molecular Diagnostics

Looking Ahead

Egyptian Biotech Reme-D Raises USD 1.45 M Pre-Series A To Expand Molecular Diagnostics

Source reference: original announcement/article.